Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

1.

The A61G EGF polymorphism is associated with development of extraaxial nervous system tumors but not with overall survival.

Almeida LO, Custódio AC, Santos MJ, Almeida JR, Clara CA, Pinto GR, Rey JA, Casartelli C.

Cancer Genet Cytogenet. 2010 Apr 1;198(1):15-21. doi: 10.1016/j.cancergencyto.2009.11.013.

PMID:
20303009
[PubMed - indexed for MEDLINE]
2.

Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.

Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ; HALT-C Trial Group.

Hepatology. 2010 Feb;51(2):585-94. doi: 10.1002/hep.23315.

PMID:
20101752
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association between EGF promoter polymorphisms and cancer risk: a meta-analysis.

Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y, Zhao W, Wu J.

Med Oncol. 2010 Dec;27(4):1389-97. doi: 10.1007/s12032-009-9392-8. Epub 2009 Dec 24.

PMID:
20033794
[PubMed - indexed for MEDLINE]
4.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.

Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.

Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x. Epub 2009 Oct 15.

PMID:
19840254
[PubMed - indexed for MEDLINE]
5.

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2429-41. doi: 10.1056/NEJMoa0707615.

PMID:
19052125
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR.

N Engl J Med. 2008 Nov 6;359(19):1995-2004. doi: 10.1056/NEJMoa0804525. Epub 2008 Oct 15.

PMID:
18923165
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

Gastroenterology. 2009 Jan;136(1):138-48. doi: 10.1053/j.gastro.2008.09.014. Epub 2008 Sep 18.

PMID:
18848939
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Molecular targeted therapies in hepatocellular carcinoma.

Llovet JM, Bruix J.

Hepatology. 2008 Oct;48(4):1312-27. doi: 10.1002/hep.22506. Review.

PMID:
18821591
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude mice.

Okamoto K, Neureiter D, Alinger B, Meissnitzer M, Sass G, Schmitz V, Di Fazio P, Wissniowski T, Gahr S, Hohenstein B, Kaufmann B, Schlösser A, Haus U, Hahn EG, Herold C, Ocker M.

Int J Oncol. 2008 Oct;33(4):733-42.

PMID:
18813786
[PubMed - indexed for MEDLINE]
10.

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome.

Lanuti M, Liu G, Goodwin JM, Zhai R, Fuchs BC, Asomaning K, Su L, Nishioka NS, Tanabe KK, Christiani DC.

Clin Cancer Res. 2008 May 15;14(10):3216-22. doi: 10.1158/1078-0432.CCR-07-4932.

PMID:
18483390
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Diagnosis and treatment of hepatocellular carcinoma.

El-Serag HB, Marrero JA, Rudolph L, Reddy KR.

Gastroenterology. 2008 May;134(6):1752-63. doi: 10.1053/j.gastro.2008.02.090. Review.

PMID:
18471552
[PubMed - indexed for MEDLINE]
12.

Growth factors as therapeutic targets in HCC.

Furuse J.

Crit Rev Oncol Hematol. 2008 Jul;67(1):8-15. doi: 10.1016/j.critrevonc.2008.02.009. Epub 2008 Apr 22. Review.

PMID:
18434184
[PubMed - indexed for MEDLINE]
13.

EGFR and VEGFR as potential target for biological therapies in HCC cells.

Giannelli G, Sgarra C, Porcelli L, Azzariti A, Antonaci S, Paradiso A.

Cancer Lett. 2008 Apr 18;262(2):257-64. doi: 10.1016/j.canlet.2007.12.001. Epub 2008 Jan 11.

PMID:
18248788
[PubMed - indexed for MEDLINE]
14.

Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.

Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.

JAMA. 2008 Jan 2;299(1):53-60. doi: 10.1001/jama.2007.65.

PMID:
18167406
[PubMed - indexed for MEDLINE]
15.

The EGF receptor is required for efficient liver regeneration.

Natarajan A, Wagner B, Sibilia M.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17081-6. Epub 2007 Oct 16. Erratum in: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19656.

PMID:
17940036
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Sequential assessment of the intrahepatic expression of epidermal growth factor and transforming growth factor-beta1 in hepatofibrogenesis of a rat cirrhosis model.

Kuriyama S, Yokoyama F, Inoue H, Takano J, Ogawa M, Kita Y, Yoshiji H, Deguchi A, Kimura Y, Himoto T, Yoneyama H, Kurokohchi K, Masaki T, Uchida N, Watanabe S.

Int J Mol Med. 2007 Feb;19(2):317-24.

PMID:
17203207
[PubMed - indexed for MEDLINE]
17.

The global health burden of infection-associated cancers in the year 2002.

Parkin DM.

Int J Cancer. 2006 Jun 15;118(12):3030-44.

PMID:
16404738
[PubMed - indexed for MEDLINE]
18.

A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.

Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell TJ, Cherny S, Doil L, Tacey K, van Luchene R, Myers A, Wavrant-De Vrièze F, Kaleem M, Hollingworth P, Jehu L, Foy C, Archer N, Hamilton G, Holmans P, Morris CM, Catanese J, Sninsky J, White TJ, Powell J, Hardy J, O'Donovan M, Lovestone S, Jones L, Morris JC, Thal L, Owen M, Williams J, Goate A.

Am J Hum Genet. 2006 Jan;78(1):78-88. Epub 2005 Nov 15.

PMID:
16385451
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Management of hepatocellular carcinoma.

Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases.

Hepatology. 2005 Nov;42(5):1208-36. No abstract available.

PMID:
16250051
[PubMed - indexed for MEDLINE]
20.

Global cancer statistics, 2002.

Parkin DM, Bray F, Ferlay J, Pisani P.

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

PMID:
15761078
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk